Research by doctors of Hyderabad-based JSPS Government Homeopathic Medical College and Indian Institute of Chemical Technology (IICT) has positively shown homeopathic medicine from snake venom, Crotalus Horridus, can arrest the multiplication of human immunodeficiency virus (HIV).
According to Dr Praveen Kumar, Head of Department of Practice of Medicine at JSPS College, Crotalus Horridus has inhibited reverse transcriptase (RT), an enzyme which is utilised by viruses like HIV and Hepatitis-B to convert the viral RNA into viral DNA so that they multiply into billions and wreck patients.
The Central Council for Research in Homeopathy (CCRH), a premium government body under AYUSH, is partnering with GHF for the summit at which scientists from eminent institutes of pure science such as IIT-B, ICMR, TIFR, BARC, Haffkine, and ICT also presented their study reports.
"The summit should bring about a paradigm shift in the way the world looks at homeopathy and shock even some practicing homeopaths who believed that the medicines had some energy effect," said Dr Rajesh Shah, organising secretary of the Foundation.
"As a virologist, I was surprised to learn that homeopathy also sources medicines from virus, bacteria and parasites, long before microbiology was fully developed," remarked Dr Abhay Chaudhary, Director Haffkine Institute, which makes polio vaccine in India.
The research by Dr Kanjaksha Ghosh of Indian Council of Medical Research (ICMR), National Institute of Immuno Hematology (NIIH) and Dr Tapas Kundu, showed that homeopathy demonstrated positive results in patients of Hemophilia - a deadly blood disease that leads to uncontrolled bleeding that cannot be managed with regular medicines.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
